Projected Income Statement: West Pharmaceutical Services, Inc.

Forecast Balance Sheet: West Pharmaceutical Services, Inc.

Forecast Balance Sheet - West Pharmaceutical Services, Inc.
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 - -685 -647 -282 -589 -499 -836 -1,242
Change - - 5.55% 56.41% -108.87% 15.21% -67.54% -48.56%
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: West Pharmaceutical Services, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 253.4 284.6 362 377 285.9 217.6 268.6 281.1
Change - 12.31% 27.2% 4.14% -24.16% -23.88% 23.4% 4.66%
Free Cash Flow (FCF) 1 330.6 439.4 414.5 276.4 468.9 439.5 629.4 738.5
Change - 32.91% -5.67% -33.32% 69.65% -6.27% 43.22% 17.33%
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: West Pharmaceutical Services, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 31.24% 30.57% 28.07% 25.17% 25.82% 28.74% 29.47% 30.58%
EBIT Margin (%) 26.92% 26.4% 23.41% 19.8% 20.25% 23.35% 24.26% 25.32%
EBT Margin (%) 26.45% 23.55% 23.66% 20.24% 19.55% 24.04% 24.48% 25.53%
Net margin (%) 23.37% 20.3% 20.12% 17.03% 16.06% 19.48% 20.3% 21.18%
FCF margin (%) 11.68% 15.22% 14.05% 9.55% 15.25% 12.85% 17.38% 18.85%
FCF / Net Income (%) 49.95% 75% 69.85% 56.1% 94.98% 65.97% 85.59% 89.02%

Profitability

        
ROA 21.67% 18.76% 16.35% 13.19% 12.48% 15.74% 14.91% 17.19%
ROE 31.59% 25.89% 21.88% 17.78% 16.85% 21.33% 20.98% 21.93%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 8.95% 9.86% 12.27% 13.03% 9.3% 6.36% 7.41% 7.18%
CAPEX / EBITDA (%) 28.64% 32.25% 43.73% 51.77% 36.02% 22.14% 25.15% 23.47%
CAPEX / FCF (%) 76.65% 64.77% 87.33% 136.4% 60.97% 49.52% 42.67% 38.06%

Items per share

        
Cash flow per share 1 7.654 9.551 10.31 8.866 10.44 10.94 13.13 14.86
Change - 24.79% 7.96% -14.03% 17.75% 4.8% 20.05% 13.17%
Dividend per Share 1 0.69 0.74 0.78 0.82 0.85 0.9478 1.022 1.238
Change - 7.25% 5.41% 5.13% 3.66% 11.51% 7.84% 21.11%
Book Value Per Share 1 31.47 36.23 39.2 37.1 46.23 44.44 49.21 55.12
Change - 15.12% 8.18% -5.35% 24.61% -3.88% 10.73% 12.03%
EPS 1 8.67 7.73 7.88 6.69 6.79 9.338 10.39 11.76
Change - -10.84% 1.94% -15.1% 1.49% 37.53% 11.27% 13.14%
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 69,661 69,661 69,661
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E 41.8x 37.6x
PBR 8.78x 7.93x
EV / Sales 7.8x 7.27x
Yield 0.24% 0.26%

EPS & Dividend

EPS & Dividend - West Pharmaceutical Services, Inc.


Y-o-Y evolution of P/E

Valuation ratios - P/E - West Pharmaceutical Services, Inc.
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - West Pharmaceutical Services, Inc.
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
390.30USD
Average target price
471.00USD
Spread / Average Target
+20.68%
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Financials West Pharmaceutical Services, Inc.